drugset / Trial / NCT01016548

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

NCT01016548 ↗

RandomizedSingle-groupOpen-label

Summary

The purpose of this study is to determine whether adults with hematologic malignancies on active systemic therapy or shortly after bone marrow transplantation need one or two doses of adjuvanted vaccine to achieve best possible rates of protection. An additional research question is whether baseline biomarkers of the cellular and humoral immune systems are associated with an antibody response to vaccination.

Timeline

Start
2009-11
Primary completion
2010-03
Completion
2010-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject AS03-adjuvanted H1N1 pandemic influenza vaccine Vaccine 0.5 ml Intramuscular